Printer Friendly
The Free Library
4,484,090 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Biological products topic

Subtopics (49)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
ImmunoCellular Therapeutics Signs Agreement with Antitope for Humanization of Antibody Product Candidates. Jul 23, 2008 690
New Technologies for Sustainable Production of Biofuels and Biobased Products To Be Introduced at Pacific Rim Summit. Jul 17, 2008 428
Power3 Medical Products Advances the Diagnostic Capabilities of the Company's Alzheimer's Disease Biomarkers. Jul 10, 2008 581
ImmunoGen, Inc. Announces Start of IMGN388 Clinical Testing. Jul 7, 2008 542
International Guidelines Will Promote Food Safety of Plant and Animal Biotech Products. Jul 4, 2008 661
Now Available - Brief Report: GM-CSF Antibodies. Report Jun 27, 2008 307
InNexus Biotechnology Announces Completion of Brokered Private Placement. Jun 23, 2008 586
Leveraging Innovations across Applications Vital for Growth in U.S. Industrial Enzymes Market. Company overview Jun 16, 2008 723
InNexus Biotechnology Announces Expansion of Patent Protection of DXL(TM) Technology. Jun 12, 2008 500
Cancer Antibodies: Competitive Positioning for Success. Jun 11, 2008 539
Symphogen Enters into Strategic Collaboration with Genentech for Antibody Therapeutics in Infectious Disease. Jun 10, 2008 502
Research and Markets: Bio Ethanol and Bio Pharmaceuticals Industries Prop up the U.S. Industrial Enzymes Market. Jun 10, 2008 640
New Product Launches Set to Unleash Multiple Growth Avenues in U.S. Monoclonal Antibodies Market. Jun 9, 2008 791
StemCells, Inc.'s New Patent Strengthens Its Leadership in the Discovery and Use of Monoclonal Antibodies for Isolating Rare Cells. Jun 6, 2008 728
Healionics Expands Research Applications for STAR(TM) Biomaterial Scaffold and Announces Upcoming Conference Presentations. Conference news Jun 5, 2008 407
AdvanSource Biomaterials to Showcase its Innovative Technology at MD&M East Expo on June 3-5 in New York. Jun 2, 2008 430
Characterization of seasonal indoor and outdoor bioaerosols in the arid environment of El Paso, Texas. Mota, Linda C.; Gibbs, Shawn G.; Green, Christopher F.; Payan, Fernanda; Tarwater, Patrick M.; Melch Report Jun 1, 2008 4750
Plant extracts minimize antioxidant activity. Jun 1, 2008 349
InNexus Biotechnology Announces Oversubscription of Private Placement Raised to $5 Million and Additional Equity Financing up to $7.5 Million. May 30, 2008 380
CardioTech Forms New Subsidiary -- AdvanSource Biomaterials -- To Accurately Reflect its Strategic Business Model. May 30, 2008 380
Biomaterials leader Polymer Technology Group (PTG) in-licenses bioresorbable polymers from Bezwada Biomedical. May 28, 2008 446
InNexus Biotechnology Announces Brokered Private Placement With Dundee Securities Corporation. May 23, 2008 407
AVEO Pharmaceuticals Granted Patent for Unique Genetic Screen to Identify Novel Cancer Drug Targets. May 22, 2008 667
Arriva Pharmaceuticals Granted Fusion Protein Patent. May 21, 2008 554
Omrix Biopharmaceuticals Announces Larry Ellberger's Appointment as Chairman of the Board and the Election of Pamela McNamara as a New Director. May 15, 2008 597
InNexus Biotechnology CEO and Scientific Advisory Board Chairman to Present at Global Healthcare and Financial Conferences. Conference news May 12, 2008 399
InNexus Biotechnology Hosts Inaugural Event of U.S. Department of Commerce. May 8, 2008 511
InNexus Biotechnology Launches Competitive Summer Intern Program -- LABapprentice. May 7, 2008 395
InNexus Biotechnology Receives 2008 Frost & Sullivan Innovation of the Year Award. May 7, 2008 547
Supply agreements in a "green" economy: the pulp and paper industry should examine existing wood supply agreements to prepare for higher energy costs and a rising wood-based bioproducts industry. Lee Keun-Hae May 1, 2008 1235
La Jolla Pharmaceutical Announces Positive 12-Month Interim Antibody Data and Provides Update for Ongoing Riquent(R) Phase 3 'ASPEN' Lupus Trial. Clinical report Apr 23, 2008 2169
European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009. Apr 16, 2008 711
Biomaterials Leader Polymer Technology Group (PTG) Says Sunshine Heart's C-Pulse(TM) Implantable Heart Assist Device, Made from Two PTG Polymers, Has Passed 5-Year Durability Testing. Apr 16, 2008 356
InNexus Biotechnology Presents Proof of Principle Data at AACR Annual Meeting 2008. Apr 15, 2008 569
Lev Pharmaceuticals Announces Agreement to Sell Intermediate Plasma Products to Biotest AG. Apr 15, 2008 572
MitoSciences Inc. and University of Oregon Complete Biotechnology Deal. Apr 15, 2008 667
MitoSciences Secures Exclusive Access to UO Biotech Portfolio with $4.6 Million Transfer Agreement. Apr 15, 2008 553
Orthovita Introduces VITASURE(TM) Absorbable Hemostat as Part of its Strategy to Leverage its Biomaterials Sales Organization. Apr 14, 2008 798
U3 Pharma Achieves Preclinical Proof of Concept for U3-1287 (AMG 888). Apr 13, 2008 434
Invitrogen Teams with MitoSciences to Improve Mitochondrial Disease Research. Apr 9, 2008 736
FDA devises initial list of drugs and biologics for REMS. Apr 8, 2008 409
LinkMed: IMED Issued European Patent. Apr 2, 2008 362
InNexus Biotechnology to Present Data at AACR. Apr 2, 2008 399
Seattle Genetics Expands SGN-35 Clinical Program with Initiation of Second Phase I Trial. Mar 28, 2008 777
InNexus Biotechnology Holds Annual General Meeting and Receives Overwhelming Mandate from Shareholders. Mar 21, 2008 391
Strengthening of Mid-Size Biopharmaceutical Companies Indicates Strong Potential for Biopharmaceutical Contract Manufacturing. Mar 17, 2008 544
Q Therapeutics, Inc. Selects Goodwin Biotechnology, Inc. for Manufacturing of Its Monoclonal Antibody. Mar 17, 2008 800
InNexus Biotechnology Engages Dundee Securities Corporation as Strategic Financial Advisor. Mar 14, 2008 435
Lev Announces FDA's Blood Products Advisory Committee to Review Cinryze (TM) (C1 inhibitor). Mar 13, 2008 950
Draft Guidelines On Subsequent Entry Biologics. McMahon, Eileen Mar 13, 2008 1026
Diverse Application Range Supports Development in Global Immunochemicals Markets. Mar 12, 2008 482
InNexus Biotechnology Announces Genetically Engineered DXLmouse(TM) Platform. Mar 12, 2008 542
Anadis Launches Products to Reduce Global Childhood Diarrhea Deaths - Oral Rotavirus & E.coli Antibodies. Mar 10, 2008 1131
Power3 Medical Files U.S. Utility Patent Application for Forty-Seven Protein Biomarkers. Mar 5, 2008 585
Biobased Products Can Increase Profitability, Environmental Benefits of Renewable Energy Industry. Mar 5, 2008 454
Symphogen Issued Patent Covering Symplex(TM) Technology for Antibody Discovery. Mar 5, 2008 487
BIO To Host Panel Discussion at WIREC 2008 on Markets for Biobased Products. Mar 3, 2008 130
Caliper and AntiCancer Announce Cross-Licensing of Fluorescent Protein Imaging Intellectual Property and Settlement of Litigation. Mar 1, 2008 673
United States Department of Health and Human Services obtains United States patent. Mar 1, 2008 123
National Enzyme Company. Mar 1, 2008 385
MODA Technology Partners and Applied Biosystems team with XOMA for deployment of SQL*LIMS Micro/EM(TM) at Berkeley, CA Manufacturing Facilities. Feb 29, 2008 680
InNexus Biotechnology Develops Diagnostics Business Based on DXL(TM) Technology. Feb 28, 2008 617
Latest Book 'Metallic Biomaterial Interfaces' is the First to Concentrate on the Highly Important Area of Metal-Based Implants and Their Improved Functionality and Acceptance by the Body. Feb 21, 2008 451
InNexus Biotechnology Announces Second Preclinical CandidateDXL702 (HER2/neu) Targeting Breast Cancer. Feb 19, 2008 797
Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma. Feb 11, 2008 490
InNexus Biotechnology Welcomes Dr. Ronald Levy, Stanford University School of Medicine Oncology Division Chief, to Scientific Advisory Board. Feb 11, 2008 549
Axela Receives Key Patent on Light Diffraction Based Assays and Opens US Facility. Feb 7, 2008 375
Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of a Second Royalty Right Based on InNexus' DXL(TM) Antibody Technology. Feb 7, 2008 624
Company Profile for InNexus Biotechnology Inc. Company overview Feb 1, 2008 111
Stiff person syndrome--management by Chinese medicine: a case study. McCann, Henry Feb 1, 2008 4852
Cell Signaling Technology and TTP LabTech Collaborate to Develop and Co-Market Antibodies and Acumen(R) Cytometric Assay Solutions for High Content Screening and Drug Discovery. Jan 31, 2008 543
Discover What Driving Factors Are Affecting Growth in Japanese Markets for Orthopedic Biomaterials. Jan 29, 2008 158
Three Leading Pharmaceutical Trade Publications Highlight InNexus' Proprietary Technology, Dynamic Cross Linking. Jan 29, 2008 651
InNexus Board Members Leroy Chiao and Glenn Williamson Featured In National Print Publications. Jan 23, 2008 729
InNexus Biotechnology Announces Dr. Capra Has Joined its Board of Directors. Jan 22, 2008 529
InNexus' Proprietary Technology, Dynamic Cross Linking, Highlighted in Two Leading Pharmaceutical Trade Publications. Jan 22, 2008 498
U.S. Market for Environmental Biotechnology Products for Waste Treatment Worth $261.3 Million by 2013. Jan 21, 2008 374
The drug pipeline; Abbott striving for an edge in the race to develop new medicines. Jan 20, 2008 1272
New Volume Examines the World Trade Organization Dispute Settlement Decision: Measures Affecting the Approval and Marketing of Biotech Products. Jan 16, 2008 370
BIO Supports U.S. Government in WTO Case Against EU on Agricultural Biotechnology Products. Jan 14, 2008 450
Xencor Receives Patent for its Proprietary Antibody Fc Optimization Technology. Jan 9, 2008 414
Analyse Therapeutic Clinical Intelligence - Rheumatoid Arthritis. Jan 7, 2008 503
ZymeQuest Licenses Proprietary Enzyme Technology to Publicly Traded Life Sciences Company. Jan 2, 2008 439
Evonik extends portfolio with plant extracts. Jan 1, 2008 170
Slim339 (proprietary combination of Garcinia cambogia and other plant extracts). Clinical report Jan 1, 2008 154
The Polymer Technology Group, Inc., a biomaterials company, has earned ISO 13485:2003 certification from BSI Management Systems, a management systems certification and notified body. Jan 1, 2008 36
Zacks Analyst Interview Highlights: Xoma, Novartis, Anesiva and NeurogesX. Dec 13, 2007 761
Dr. Maurizio Zanetti Joins InNexus Biotechnology Scientific Advisory Board. Dec 13, 2007 433
Dr. Judith James Joins InNexus Biotechnology Scientific Advisory Board. Dec 11, 2007 630
Introducing the Brand New Report on Business Strategies for Different Types of Biogenerics. Dec 6, 2007 808
Biomaterials Leader Polymer Technology Group (PTG) Earns ISO 13485:2003 Certification; Company Also Achieves ISO 9001:2000 Recertification. Dec 3, 2007 534
Power3 Medical Blood Serum Diagnostic Test Featured in Popular Science Magazine. Nov 27, 2007 645
Dyax and MorphoSys Sign License Agreement on Antibody-Related Patents. Nov 20, 2007 1037
Hollis-Eden Pharmaceuticals Presents Data Demonstrating TRIOLEX(TM) Provides Benefit in Additional Animal Model of Rheumatoid Arthritis. Nov 19, 2007 1263
Morphotek Receives U.S. Patent Regarding Methods for Generating Genetically Altered Antibodies with Enhanced Affinity and Antibodies Produced by Them. Nov 19, 2007 495
Aveda's Outer Peace Cooling Masque ($35) is an at-home treatment infused with plant extracts to instantly soothe skin while helping to unclog pores. Nov 1, 2007 43
Panacea announces selection of PAN-622 - a fully human sequence monoclonal antibody against HAAH - as its lead cancer therapeutic product. Nov 1, 2007 793
Vaccinex announces award of key patent in Europe for its antibody discovery technology. Nov 1, 2007 147
Novimmune obtains United States patent. Nov 1, 2007 84
National Stem in final stage negotiations for exclusive licensing of its recently discovered biomaterial for anti-aging applications. Sep 1, 2007 333

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles